Skip to content
DE

Mushroom coffee: effects, caffeine and risks

Clinical review pending

What is proven about mushroom coffee? Caffeine, lion's mane, cordyceps, reishi and chaga compared, with study doses, limits and kidney risks.

Editorial draft. The medical statements in the source text and the way sources are matched to them have not yet been independently checked; clinical sign-off is pending.

Mushroom coffee combines coffee with mushroom extracts and usually delivers 50 to 100 mg of caffeine per serving. That caffeine makes you more alert is well established in randomized controlled trials. For lion’s mane, cordyceps, reishi and chaga, the evidence at the doses found in commercial products is limited or confined to lab and animal experiments. For chaga, there are also case reports of kidney damage from oxalate deposits after prolonged use.

What mushroom coffee is

Mushroom coffee is ground coffee mixed with one or more functional mushroom extracts. The most common additions are lion’s mane, cordyceps, reishi and chaga. It is brewed like regular coffee and marketed for better focus, steadier energy and a supposedly stress-regulating, “adaptogenic” effect.

Between 2021 and 2023, the product category grew quickly. Post-pandemic anxiety, a wellness culture keen on self-experimentation and the wish for more mindful morning rituals all played a part. Direct-to-consumer brands and TikTok creators promoted mushroom coffee as a conscious alternative that causes fewer jitters.

The marketing claims for mushroom coffee generally fall into four categories:

  • Sustained focus and cognitive performance (justified by lion’s mane)

  • Energy and stamina without jitters (justified by caffeine + cordyceps)

  • Better stress regulation and balanced cortisol (justified by reishi)

  • Antioxidant effects and immune support (justified by chaga)

What is in the cup?

Each ingredient comes with its own mechanisms, study doses and evidence. The combination as a whole has not been studied at the doses in commercial servings.

Caffeine (from the coffee base)

Caffeine is by far the best-studied ingredient in the blend. Most servings of mushroom coffee provide about 50–100 mg, roughly as much as half a typical cup of drip coffee. Decades of research have characterized the cognitive and physical performance effects of caffeine well, with a dose-response relationship described in the range of 3–6 mg per kilogram of body weight. Source link 1 Source link 2

Lion’s mane (Hericium erinaceus)

Lion’s mane is an edible mushroom whose main bioactive compounds are hericenones in the fruiting body and erinacines in the mycelium, the network of fungal threads. The most frequently cited human study used 3 g of dried powder per day over 16 weeks, far more than most servings of mushroom coffee provide. Mycelial cultures of H. erinaceus contain cyathane diterpenoids that stimulate NGF and BDNF production, and the composition differs depending on whether fruiting bodies or mycelium grown on grain is used. Source link

Cordyceps (typically Cordyceps militaris in commercial blends)

The cordyceps in most commercial mushroom coffee blends is cultivated Cordyceps militaris, not the wild-harvested Cordyceps sinensis used in traditional medicine. A 2010 study gave a CS-4 strain to healthy older adults for 12 weeks at about 1 g per day; a separate trial used C. militaris in recreational athletes. Mushroom coffee servings typically provide fractions of these doses. Source link

Reishi (Ganoderma lucidum)

Reishi is a traditional Asian medicinal mushroom marketed for cardiovascular support, immune support and stress. The most relevant human study used 1.44 g of reishi powder per day over 12 weeks to assess cardiovascular outcomes. Most servings of mushroom coffee provide much less than the dose studied.

Chaga (Inonotus obliquus)

Chaga is a birch fungus marketed as an antioxidant and for immune support. There are no consistent study results in humans at commercial doses. Chaga polysaccharides show marked antioxidant activity in lab models. At the same time, there are documented safety concerns about its constituents, including its high oxalate content. This matters most for people prone to calcium oxalate stones. Source link 1 Source link 2

Which mechanisms are discussed

Terms such as “NGF,” “cortisol balance” and “antioxidant” turn up constantly in mushroom coffee marketing. They refer to real biological processes. The evidence in humans, however, is weaker, and the doses in commercial servings lower, than the advertising suggests.

Caffeine blocks adenosine receptors, especially the A1 and A2A subtypes, which suppresses the brain’s natural tiredness signals. The result is better attention, alertness and reaction time. This mechanism is well characterized across cognitive, physical and occupational performance, with a dose-response relationship of 3–6 mg per kilogram of body mass. It is the best-supported mechanism in the drink. Source link 1 Source link 2

One proposed mechanism for lion’s mane is support of cognitive function through nerve growth factor (NGF) and brain-derived neurotrophic factor (BDNF). Cell culture studies have shown that H. erinaceus extracts stimulate neurite growth and that hericerin derivatives activate neurotrophic ERK1/2 signaling in hippocampal neurons. Research on these pathways makes an effect on cognitive function biologically plausible. However, no NGF or BDNF changes have been confirmed in people consuming the doses found in mushroom coffee. Source link 1 Source link 2 Source link 3

Bioactive cordyceps compounds, including cordycepin and adenosine analogs, are said to support ATP synthesis and oxygen use: this is the basis for the claimed stamina effect. In healthy older adults, cordyceps supplementation improved metabolic and ventilatory thresholds, and C. militaris improved tolerance of high-intensity exercise in recreational athletes. Reishi triterpenes are thought to act on cardiovascular and immune endpoints, but most human data come from small RCTs or open-label studies without blinding. Chaga polysaccharides show antioxidant activity in vitro and in animal models, and their structure-activity relationships are reasonably well described at the preclinical level; data on health outcomes in humans are missing. The antioxidant claims for chaga therefore rest on animal and cell culture experiments. Source link 1 Source link 2 Source link 3

What human studies show

The claims behind mushroom coffee can be split into two components: the coffee (caffeine) and the functional mushrooms mixed in (lion’s mane, cordyceps, reishi and chaga).

Caffeine and attention: strong evidence

A meta-analysis in athletes confirmed that caffeine improves energy, mood and attention. A comprehensive narrative review of caffeine’s effects on cognitive, physical and occupational performance draws on decades of RCT data. The dose-response relationship and the mechanism are well described. This is the best-supported effect of the drink, and it comes from the coffee. Source link 1 Source link 2

Lion’s mane and cognition: moderate evidence in mild impairment, limited in healthy people

A key double-blind, placebo-controlled study looked at adults with mild cognitive impairment. At 3 g per day for 16 weeks, cognitive test scores improved. The dose was far above the usual amount in mushroom coffee, and the people studied were a clinical group. In healthy adults, a single dose improved processing speed and reduced subjective stress; longer-term effects, by contrast, were modest. A more recent double-blind RCT in healthy younger adults found only small effects on certain cognitive domains. For healthy adults at typical mushroom coffee doses, there are no repeatedly confirmed results from large randomized controlled trials. Source link 1 Source link 2 Source link 3

Cordyceps, stamina and VO2: limited, conflicting evidence

CS-4 supplementation improved metabolic and ventilatory thresholds in healthy older adults, and C. militaris improved tolerance of high-intensity exercise in recreational athletes. On the other hand, CordyMax CS-4 did not improve endurance performance in trained cyclists, and a commercial herbal formula containing cordyceps showed mixed performance effects. The studies are small, often use combination products, and the results conflict. A cordyceps effect at the doses found in mushroom coffee blends has not been shown. Source link 1 Source link 2 Source link 3 Source link 4

Reishi, the cardiovascular system and immune function: limited evidence, mostly preclinical

A controlled human study found no change in blood pressure or BMI, but a slight reduction in insulin resistance with reishi at 1.44 g per day over 12 weeks. Blood-pressure-lowering effects in hypertensive rats support a possible mechanism at the preclinical level, but animal data cannot be carried over directly to outcomes in humans. Claims about cardiovascular and immune conditions are not supported by repeatedly confirmed randomized human trials at mushroom coffee doses. Source link 1 Source link 2

Chaga and antioxidant or immune effects: animal data and anecdotal human reports

Evidence for the antioxidant mechanism of chaga polysaccharides comes from in vitro and animal studies. Randomized human trials on the advertised health outcomes are missing. Set against this are case reports of oxalate nephropathy after prolonged chaga use. While the claimed antioxidant benefits remain preclinical, the kidney damage described has occurred in humans. Source link

Safety, contraindications and the chaga concern

Drinking chaga every day raises the cumulative oxalate load over time. One case report describes chaga-induced oxalate nephropathy (kidney damage from deposits of oxalate crystals) that presented as nephrotic syndrome, and a separate case report with a literature review documents end-stage kidney disease after long-term chaga intake. These are case reports, not controlled studies. Even so, they document serious harm in people who had been taking chaga regularly. Source link 1 Source link 2

Caffeine can interact with anti-anxiety medicines, certain stimulants and medicines affected by changes in lithium clearance. At supplement doses, reishi may interact with anticoagulant or antiplatelet medicines, a theoretical interaction that should be discussed with the prescriber. Lion’s mane currently has only minimal documented interactions with other medicines.

Particular caution applies to people with mushroom allergies (rare cross-reactivity is possible), people who are pregnant or breastfeeding (limited safety data on mushroom extracts as supplements mean a doctor should be consulted first), people with reduced kidney function or a history of oxalate stones (especially relevant for blends containing chaga) and people on anticoagulant therapy (relevant for blends containing reishi).

Effects on lab values. Chaga taken daily raises the cumulative oxalate load. This matters when monitoring creatinine, eGFR and urinary oxalate. Caffeine on the morning of a cortisol test affects the result; it is generally recommended to pause caffeine for at least 12 hours before a cortisol measurement. The exact procedure should be agreed with the practice ordering the test. Polysaccharides from mushroom extracts could in theory affect immune markers, which should be taken into account when interpreting changes in hsCRP.

The contraindications above, in summary:

  • Pregnancy / breastfeeding. Limited safety data on mushroom extracts as supplements; check with a doctor first.

  • History of kidney dysfunction, oxalate kidney stones or active nephropathy. Do not use blends containing chaga daily.

  • Anticoagulant or antiplatelet therapy. Discuss blends containing reishi with the prescriber beforehand.

  • Caffeine sensitivity/anxiety/sleep problems: even reduced-caffeine mushroom coffee can produce caffeine effects.

  • Documented case reports. Chaga oxalate nephropathy and end-stage kidney disease in chronic users.

If any of these apply, it makes sense to get medical advice first.

Which biomarkers the source text names for monitoring

How you feel does not by itself show whether a functional drink has the claimed effects. For that, the source text proposes comparing lab values on day 0 and day N: at the same lab and under the same morning conditions.

  • Cortisol AM: A morning cortisol measurement captures the current activity of the hypothalamic-pituitary-adrenal axis (HPA axis). The source text links it to the advertised stress-regulating effect of reishi and lion’s mane. Caffeine skews the result, so the blood draw should happen before any caffeine. If this claimed effect occurs in a given person, morning cortisol trends toward the middle of the reference range over 8–12 weeks.

  • hsCRP: High-sensitivity C-reactive protein reflects systemic inflammation. The source text connects this marker to the antioxidant and immune claims for chaga and reishi. If a corresponding effect shows up in humans at commercial doses, hsCRP should fall. At the same time, the daily oxalate load from chaga remains a separate risk factor for the kidneys.

  • Fasting glucose: A metabolic marker relevant to the energy claims for cordyceps and caffeine and to general monitoring of metabolic health. Caffeine has a strong effect on fasting glucose levels. It is therefore generally recommended to pause caffeine for 12 or more hours before the blood draw. The timing should be agreed with the practice ordering the test.

  • Creatinine + eGFR: Kidney function markers that are essential context for anyone drinking a chaga-containing blend daily. Kidney function before starting is an important safety value; a repeat check after 12 weeks of regular use (sooner if symptoms appear) is a reasonable monitoring interval given the documented case reports of oxalate nephropathy.

If the markers change as the proposed mechanism predicts (regulated morning cortisol, lower hsCRP, stable fasting glucose and unchanged kidney values), the source text counts this as an effect of daily use. If no such change appears, that too is information for deciding whether to keep taking it for another six months.

Who mushroom coffee may suit

Mushroom coffee could suit someone who wants a morning ritual with less caffeine: 50–100 mg compared with 200 mg or more in a typical drip coffee. For mild cognitive complaints, the drink with caffeine and low-dose lion’s mane may be an addition, but it does not replace a proper medical workup. Simply enjoying the morning ritual is also an understandable reason.

Anyone reaching for mushroom coffee to fight anxiety, chronic insomnia, suspected hormonal disorders or cognitive decline is reaching for the wrong tool. For these complaints there are first-line medical treatments with much stronger evidence than any functional drink. Anyone with kidney dysfunction or a history of oxalate stones should avoid blends containing chaga entirely.

Better-studied options for similar goals

For specific goals, there are more targeted approaches than a blend of different additives.

Regular coffee with a known amount of caffeine. Caffeine is the best-supported ingredient. For more alertness, you can use the studied component directly, within the dose range from the ISSN (International Society of Sports Nutrition) position stand. Source link 1 Source link 2

Lion’s mane as a single product at a studied dose. For cognitive goals, the source text points to a single-ingredient product with an amount closer to the key study (about 3 g of fruiting body powder per day). That way you use the component that was actually studied, without the daily chaga oxalate load of many blends. Source link

Clinical workup of the underlying symptom. If the reason for reaching for mushroom coffee is chronic fatigue, anxiety, a suspected adrenal problem or cognitive issues, a medical workup (cortisol axis, thyroid panel, B12, ferritin, mental health assessment) provides far stronger evidence than any functional drink.

Clarify the starting point before you try it

Wellness rituals are often cheap to try. Trying one does not tell you whether it works. The source text sets changes in mechanistically relevant biomarkers (morning cortisol, hsCRP, fasting glucose and kidney values) as an objective yardstick against the vague feeling of having more energy.

If the reason for reaching for mushroom coffee is chronic anxiety, persistent fatigue, suspected HPA axis dysregulation or early cognitive changes, a medical workup is warranted. The source text names a primary care checkup with thyroid values, cortisol, blood count and ferritin, or a referral to a specialist.

What can be said about mushroom coffee

Mushroom coffee is a low-caffeine coffee mixed with functional mushroom extracts. There is strong evidence for caffeine’s effect on attention and reaction time. For lion’s mane, there is moderate evidence in mild cognitive impairment, though at much higher doses than in commercial servings. Small cordyceps studies on stamina give conflicting results. Human studies on reishi are limited to small randomized trials. Antioxidant effects of chaga have been studied preclinically; at the same time, there are case reports of oxalate nephropathy after prolonged use. Most people get a pleasant morning ritual with less caffeine. Whether the proposed mechanisms actually change biomarkers is a separate question that can be measured.

Frequently asked questions

Does mushroom coffee actually work?

It depends on which effect you mean: caffeine’s effects on attention and reaction time are well established, but the evidence for the mushrooms ranges from purely preclinical data (most of the cordyceps stamina claims) to a small randomized trial with a positive result in mild cognitive impairment (lion’s mane). For a healthy adult, caffeine is the main active ingredient. Source link 1 Source link 2

What does research say about mushroom coffee?

The research gives a mixed picture: the evidence for caffeine is strong; for lion’s mane there is limited evidence in healthy adults but moderate evidence in mild cognitive impairment; cordyceps stamina effects conflict across different populations; and for reishi and chaga, clinical evidence in humans is missing. Most claimed benefits remain anecdotal or come from animal studies, and only the proven effects of caffeine have stronger support. Source link 1 Source link 2

How much caffeine and mushroom extract does mushroom coffee contain?

Typical servings of mushroom coffee contain 50–100 mg of caffeine (about half a cup of coffee) plus 500–2,000 mg of a blend of several mushrooms. The mushroom doses studied in human trials (for example 3 g of lion’s mane), however, are much higher than most mushroom coffee servings. Source link

Does mushroom coffee wake you up without the jitters?

Mushroom coffee may cause fewer jitters than strong drip coffee, mainly because of its lower caffeine content and not because of the mushrooms themselves. Research suggests that mushroom adaptogens have no established whole-body effects in humans. Claims about alertness should therefore be judged mainly by the caffeine dose.

Who should avoid mushroom coffee?

People with kidney disease or chronic kidney disease should avoid mushroom coffee, particularly because of chaga’s oxalate content, which raises the cumulative oxalate load, and the case reports of oxalate nephropathy in chronic users. Caution also applies to people with caffeine sensitivity, people taking anticoagulants (reishi at supplement doses), people with mushroom allergies and anyone taking medicines that could cause interactions. In these cases, medical advice makes sense. Source link 1 Source link 2

What side effects does mushroom coffee have?

The side effects most often reported in healthy adults are digestive complaints, jitters and sleep problems. These are attributed to the caffeine. Mushroom-specific side effects (mild digestive upset, rare allergic reactions) are uncommon at typical mushroom coffee doses, but become more frequent with concentrated extract products.

Does mushroom coffee help with focus or anxiety, and does it affect cortisol?

How mushroom coffee affects focus, anxiety and cortisol depends on its caffeine content, the mix of mushroom species (for example lion’s mane for cognitive function or reishi for relaxation), and whether the doses of the individual extracts are stated or only the total amount of a proprietary blend. Most mushroom coffees contain less caffeine than regular coffee plus mushrooms marketed as adaptogens, but individual results vary, and more research is needed to confirm specific health claims.

Which biomarkers does the source text name for monitoring?

It names morning cortisol (to assess the adaptogenic/HPA axis claim), hsCRP (to measure inflammation and the antioxidant effects of chaga and reishi) and fasting glucose/HbA1c (to assess the metabolic effect of cordyceps and caffeine). The source text proposes measuring before starting and after 8–12 weeks to track changes in the markers linked to the proposed mechanisms.

Sources and literature from the source text

  • McLellan TM, Caldwell JA, Lieberman HR (2016). A review of caffeine’s effects on cognitive, physical and occupational performance. Neuroscience and biobehavioral reviews, 71, 294-312. https://doi.org/10.1016/j.neubiorev.2016.09.001

  • Guest NS, VanDusseldorp TA, Nelson MT, Grgic J, Schoenfeld BJ, Jenkins NDM, Arent SM, Antonio J, Stout JR, Trexler ET, Smith-Ryan AE, Goldstein ER, Kalman DS, Campbell BI (2021). International society of sports nutrition position stand: caffeine and exercise performance. Journal of the International Society of Sports Nutrition, 18(1), 1. https://doi.org/10.1186/s12970-020-00383-4

  • Rupcic Z, Rascher M, Kanaki S, Köster RW, Stadler M, Wittstein K (2018). Two New Cyathane Diterpenoids from Mycelial Cultures of the Medicinal Mushroom Hericium erinaceus and the Rare Species, Hericium flagellum. International journal of molecular sciences, 19(3). https://doi.org/10.3390/ijms19030740

  • Hirsch KR, Smith-Ryan AE, Roelofs EJ, Trexler ET, Mock MG (2017). Cordyceps militaris Improves Tolerance to High-Intensity Exercise After Acute and Chronic Supplementation. Journal of dietary supplements, 14(1), 42-53. https://doi.org/10.1080/19390211.2016.1203386

  • Zhang S, Zhang W, Wu X, Li S, Shi D, Li H, Liu T, Gong A (2026). Nutrients, 18(7). https://doi.org/10.3390/nu18071125

  • Cui M, Wang X, Yu T, Ma H, Xin J, Zhang X (2026). Preparation, bioactivities, structure-activity relationships, applications, and safety concerns of Inonotus obliquus polysaccharides: A review. International journal of biological macromolecules, 350, 150953. https://doi.org/10.1016/j.ijbiomac.2026.150953

  • Lai PL, Naidu M, Sabaratnam V, Wong KH, David RP, Kuppusamy UR, Abdullah N, Malek SN (2013). Neurotrophic properties of the Lion’s mane medicinal mushroom, Hericium erinaceus (Higher Basidiomycetes) from Malaysia. International journal of medicinal mushrooms, 15(6), 539-54. https://doi.org/10.1615/intjmedmushr.v15.i6.30

  • Martínez-Mármol R, Chai Y, Conroy JN, Khan Z, Hong SM, Kim SB, Gormal RS, Lee DH, Lee JK, Coulson EJ, Lee MK, Kim SY, Meunier FA (2023). Hericerin derivatives activates a pan-neurotrophic pathway in central hippocampal neurons converging to ERK1/2 signaling enhancing spatial memory. Journal of neurochemistry, 165(6), 791-808. https://doi.org/10.1111/jnc.15767

  • Chong PS, Fung ML, Wong KH, Lim LW (2019). Therapeutic Potential of Hericium erinaceus for Depressive Disorder. International journal of molecular sciences, 21(1). https://doi.org/10.3390/ijms21010163

  • Chen S, Li Z, Krochmal R, Abrazado M, Kim W, Cooper CB (2010). Effect of Cs-4 (Cordyceps sinensis) on exercise performance in healthy older subjects: a double-blind, placebo-controlled trial. Journal of alternative and complementary medicine (New York, N.Y.), 16(5), 585-90. https://doi.org/10.1089/acm.2009.0226

  • Lorenzo Calvo J, Fei X, Domínguez R, Pareja-Galeano H (2021). Caffeine and Cognitive Functions in Sports: A Systematic Review and Meta-Analysis. Nutrients, 13(3). https://doi.org/10.3390/nu13030868

  • Mori K, Inatomi S, Ouchi K, Azumi Y, Tuchida T (2009). Improving effects of the mushroom Yamabushitake (Hericium erinaceus) on mild cognitive impairment: a double-blind placebo-controlled clinical trial. Phytotherapy research : PTR, 23(3), 367-72. https://doi.org/10.1002/ptr.2634

  • Docherty S, Doughty FL, Smith EF (2023). The Acute and Chronic Effects of Lion’s Mane Mushroom Supplementation on Cognitive Function, Stress and Mood in Young Adults: A Double-Blind, Parallel Groups, Pilot Study. Nutrients, 15(22). https://doi.org/10.3390/nu15224842

  • Surendran G, Saye J, Binti Mohd Jalil S, Spreadborough J, Duong K, Shatwan IM, Lilley D, Heinrich M, Dodd GF, Surendran S (2025). Acute effects of a standardised extract of Hericium erinaceus (Lion’s Mane mushroom) on cognition and mood in healthy younger adults: a double-blind randomised placebo-controlled study. Frontiers in nutrition, 12, 1405796. https://doi.org/10.3389/fnut.2025.1405796

  • Parcell AC, Smith JM, Schulthies SS, Myrer JW, Fellingham G (2004). Cordyceps Sinensis (CordyMax Cs-4) supplementation does not improve endurance exercise performance. International journal of sport nutrition and exercise metabolism, 14(2), 236-42. https://doi.org/10.1123/ijsnem.14.2.236

  • Earnest CP, Morss GM, Wyatt F, Jordan AN, Colson S, Church TS, Fitzgerald Y, Autrey L, Jurca R, Lucia A (2004). Effects of a commercial herbal-based formula on exercise performance in cyclists. Medicine and science in sports and exercise, 36(3), 504-9. https://doi.org/10.1249/01.mss.0000125157.49280.af

  • Chu TT, Benzie IF, Lam CW, Fok BS, Lee KK, Tomlinson B (2012). Study of potential cardioprotective effects of Ganoderma lucidum (Lingzhi): results of a controlled human intervention trial. The British journal of nutrition, 107(7), 1017-27. https://doi.org/10.1017/S0007114511003795

  • Shevelev OB, Seryapina AA, Zavjalov EL, Gerlinskaya LA, Goryachkovskaya TN, Slynko NM, Kuibida LV, Peltek SE, Markel AL, Moshkin MP (2018). Hypotensive and neurometabolic effects of intragastric Reishi (Ganoderma lucidum) administration in hypertensive ISIAH rat strain. Phytomedicine : international journal of phytotherapy and phytopharmacology, 41, 1-6. https://doi.org/10.1016/j.phymed.2018.01.013

  • Kwon O, Kim Y, Paek JH, Park WY, Han S, Sin H, Jin K (2022). Chaga mushroom-induced oxalate nephropathy that clinically manifested as nephrotic syndrome: A case report. Medicine, 101(10), e28997. https://doi.org/10.1097/MD.0000000000028997

  • Lee S, Lee HY, Park Y, Ko EJ, Ban TH, Chung BH, Lee HS, Yang CW (2020). Development of End Stage Renal Disease after Long-Term Ingestion of Chaga Mushroom: Case Report and Review of Literature. Journal of Korean medical science, 35(19), e122. https://doi.org/10.3346/jkms.2020.35.e122

Origin and editorial review status

Translated and prepared for Nutrient Desk from the source article. Promotional membership, newsletter and lab offers were removed. The bibliography is kept in its original form so each work can be identified unambiguously. Figures and source references were carried over; which piece of evidence supports which individual statement must be checked before publication. This draft is not cleared for indexing.